Medicine
Neupro 2 mg/24 hours transdermal patch
Neupro 2 mg/24 hours transdermal patch is a prescription medicine containing Rotigotine for transdermal use, marketed by UCB, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° - 25°C (68° - 77°F), excursions permitted between 15° - 30°C (59°…
Key facts
- Active ingredient (INN)
- Rotigotine
- Brand
- Neupro
- Strength
- 2 mg/24 hours
- Dosage form
- Transdermal patch
- Route
- Transdermal
- Packs
- 30 pouches, 7 pouches
- Marketing authorisation holder
- UCB
- Manufacturer
- UCB
- Origin register
- US FDA, United States
- Storage
- Store at 20° - 25°C (68° - 77°F), excursions permitted between 15° - 30°C (59° - 86°F). NEUPRO should be stored in the original pouch. Do not store outside of pouch.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N04BC09 Rotigotine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 April 2012
- Identifiers
- RxCUI 722253, 722256, 722279 +7DailyMed set ID 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0NDC 50474-802Application NDA021829
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Rotigotine
Clinical summary
Rotigotine is a nonergot dopamine agonist indicated for the treatment of parkinson's disease, among other approved uses. It is available as transdermal patches and kits. MedsAcross supplies Rotigotine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RotigotineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Neupro prescribing information (UCB) · U.S. National Library of Medicine, DailyMed
- Neupro: European public assessment report (EPAR) · European Medicines Agency
Need Neupro 2 mg/24 hours transdermal patch for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.